Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
35.12
+0.52 (1.50%)
At close: Dec 5, 2025, 4:00 PM EST
36.93
+1.81 (5.15%)
After-hours: Dec 5, 2025, 7:54 PM EST
Indivior Market Cap
Indivior has a market cap or net worth of $4.38 billion as of December 5, 2025. Its market cap has increased by 231.47% in one year.
Market Cap
4.38B
Enterprise Value
4.30B
1-Year Change
231.47%
Ranking
Category
Stock Price
$35.12
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $4.38B, an increase of 186.49%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.38B | 182.28% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |